Megaron Athens International Conference Centre
Athens, 10-12/10/2019

The Hellenic Society for the Study of Bone Metabolism (HSSBM) and the Dutch Society for Calcium and Bone Metabolism (NVCB), successfully carried out a Joint Meeting in Megaron Athens International Conference Centre, from October 10th to October 12th 2019.

IASIS PHARMA was actively present in the conference, proving its high devotion in the field of osteoporosis and other bone diseases.

All HCPs attending the conference, visited IASIS PHARMA exhibition stand and got information about the company’s high-quality products.

Special interest was shown for the Pharma Grade effervescent line products, manufactured at IASIS PHARMA facilities:

  • MAG-IASIS®, which is a combination of Magnesium salts (citric & aspartic), equivalent to 243mg of Magnesium,
  • Calciform D3®, the original form of Calcium + Vitamin D combination (Calcium carbonate + Cholecalciferol: 1000mg + 880 IU),
  • Calciform®, containing 500mg of Calcium carbonate.

Additional interest was shown for the GLUCOFREE® & GLUCOPLUS®, metformin 850mg & 1000mg respectively. Metformin belongs to OHAs (Oral Hypoglycemic Agents) and more specifically, in the pharmacotherapeutic category of Biguanides (ATC code: A10BA02).

Metformin is the 1st therapeutic step in every Diabetes Mellitus Type II treatment algorithm.

Glucofree® is available in packages of 60 f.c. tabs.

Glucoplus® is available in packages of 30 f.c. tabs.